Pavel Mirovsky

2013

In 2013, Pavel Mirovsky earned a total compensation of $823.9K as President and General Manager, Europe at Valeant Pharmaceuticals International, a 51% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$377,275
Salary$425,003
Other$21,625
Total$823,903

Mirovsky received $425K in salary, accounting for 52% of the total pay in 2013.

Mirovsky also received $377.3K in non-equity incentive plan and $21.6K in other compensation.

Rankings

In 2013, Pavel Mirovsky's compensation ranked 7,463rd out of 12,286 executives tracked by ExecPay. In other words, Mirovsky earned more than 39.3% of executives.

ClassificationRankingPercentile
All
7,463
out of 12,286
39th
Division
Manufacturing
2,685
out of 4,612
42nd
Major group
Chemicals And Allied Products
836
out of 1,462
43rd
Industry group
Drugs
626
out of 1,156
46th
Industry
Pharmaceutical Preparations
495
out of 890
44th
Source: SEC filing on April 9, 2015.

Mirovsky's colleagues

We found seven more compensation records of executives who worked with Pavel Mirovsky at Valeant Pharmaceuticals International in 2013.

2013

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2013

Laizer Kornwasser

Valeant Pharmaceuticals International

Group Chairman

2013

Daniel Wechsler

Valeant Pharmaceuticals International

Group Chairman

2013

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2013

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2013

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2013

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

You may also like